By Panels

DNA testing services are listed below by  panel. Click on a test for a brief description with a link to a detailed assay summary which includes specimen requirements.

For the current price list, please email us at [email protected] with your name, title and institution.

Multiple and complementary tests are available for comprehensive diagnostic testing.

For most genes, sequence analysis covers the entire coding region and associated splice junctions. For many genes, deletion/duplication analysis is also available.
(Mutation and selected copy number analysis of 49 genes: ABL1, AKT1, ALK, APC, ATM, BRAF, CDH1, CDKN2A, CSF1R, CTNNB1, EGFR, ERBB2, ERBB4, EZH2, FBXW7, FGFR1, FGFR2, FGFR3, GNA11, GNAQ, GNAS, HNF1A, HRAS, IDH1, IDH2, JAK2, JAK3, KDR, KIT, KRAS, MET, MLH1, MPL, NOTCH1, NPM1, NRAS, PDGFRA, PIK3CA, PTEN, PTPN11, RB1, RET, SMAD4, SMARCB1, SMO, SRC, STK11, TP53, VHL)
(Analysis of fusions involving 53 genes commonly rearranged in solid tumors: AKT3, ALK, ARHGAP26, AXL, BRAF, BRD3, BRD4, EGFR, ERG, ESR1, ETV1, ETV4, ETV5, ETV6, EWSR1, FGFR1, FGFR2, FGFR3, FGR, INSR, MAML2, MAST1 MAST2 MET MSMB, MUSK, MYB, NOTCH1, NOTCH2, NRG1, NTRK1, NTRK2, NTRK3, NUMBL, NUTM1, PDGFRA, PDGFRB, PIK3CA, PKN1, PPARG, PRKCA, PRKCB, RAF1, RELA, RET, ROS1, RSPO2, RSPO3, TERT, TFE3, TFEB, THADA, TMPRSS2)
(OncoMutations PLUS OncoFusions)

(Comprehensive mutation analysis of genes associated with hematological malignancies: ASXL1, ATM, BCOR, BIRC3, BRAF, BTK, CALR, CARD11, CBL, CBLB, CCND1, CCND3, CD79A, CD79B, CDKN2A, CEBPA, CREBBP, CSF3R, DNMT3A,EP300, ETV6, EZH2, FBXW7, GATA1, GATA2, HRAS, ID3, IDH1, IDH2, IKZF1, IL7R, JAK1, JAK2, JAK3, KDM6A, KIT, KMT2A, KMT2C, KMT2D, KRAS, MEF2B, MIR142, MPL, MYC, MYD88, NOTCH1, NOTCH2, NPM1, NRAS, PAX5, PDGFRA, PHF6, PIK3CA, PTEN, PTPN11, RUNX1, SETBP1, SF3B1, SPI1, SRSF2, STAG2, SUZ12, TCF3, TET2, TNFAIP3, TP53, U2AF1, UBR5, WHSC1, WHSC1L1, WT1, ZRSR2)

(Analysis of fusions involving 23 genes associated with hematological malignancies and related disorder: ABL1, ABL2, ALK, BCR, CBFB, CRLF2, CSFIR, FGFR1, JAK2, KMT2A (MLL), MECOM, MKL1, NOTCH1, NUP214, PDGFRA, PDGFRB, PICALM, RARA, RBM15, RUNX1,  RUNX1T1, TAL1, TCF3)

(OncoHemeMutations PLUS OncoHemeFusions)
(Targeted analysis for 124 cancer hotspot mutations in the KRAS, NRAS and HRAS genes by next generation sequencing.)
(HNPCC Immunohistochemistry- MLH1, MSH2, MSH6, PMS2)
(APC and MUTYH: Full gene sequencing, APC: MLPA)